» Authors » Magdy M Youssef

Magdy M Youssef

Explore the profile of Magdy M Youssef including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 75
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassan B, Omran M, Youssef M, Refaat M, Abouzid A, Abdel Wahab A, et al.
Technol Cancer Res Treat . 2024 Dec; 23:15330338241291637. PMID: 39703128
Background And Aims: Thyroid cancer, a prevalent endocrine malignancy, often presents as thyroid nodules, whose benign or malignant nature is challenging to determine. This study aims to identify circulating miRNA...
2.
Abd El-Lateef H, Bafail D, Alhalees N, Toson E, Almaaty A, Elsayed E, et al.
RSC Adv . 2024 Jul; 14(32):23495-23504. PMID: 39071480
Novel derivatives of the 2-(quinoline-4-carbonyl)hydrazide scaffold carrying the acrylamide moiety were synthesized and tested for their cytotoxic efficacy against the breast carcinoma MCF-7 cell line. The most active members 6a,...
3.
Mokhtar W, Elsaid A, Elrefaey A, Saleh M, Youssef M
Biochem Genet . 2024 Jul; PMID: 39028381
Nephrotic syndrome is one of the most prevalent pediatric kidney illnesses seen in pediatric nephrology clinics. Steroid resistance in children with nephrotic syndrome is a primary cause of renal failure...
4.
Mukhlif R, Abol-Enein H, Elsaid A, Abdelkhalek M, Khatab H, Youssef M
Mol Biol Rep . 2024 Jul; 51(1):815. PMID: 39009695
Background: Urinary bladder cancer (UBC)is a common tumor of the urinary tract. Objectives: To assess the diagnostic significance of IL6 rs1800796 gene polymorphism and IL6 serum level among Egyptian patients...
5.
Nafie M, Kahwash S, Youssef M, Dawood K
Arch Pharm (Weinheim) . 2024 Jun; 357(9):e2400225. PMID: 38822393
The current review outlines all possible recent synthetic platforms to quinoxaline derivatives and the potent stimulated apoptosis mechanisms targeted by anticancer therapies. The currently reported results disclosed that quinoxaline derivatives...
6.
Al-Adl M, Youssef M, El-Sebaie A, Refaat S, El-Said A
Oncol Res . 2024 Apr; 32(4):785-797. PMID: 38560574
Cytochromes P450 (CYPs) play a prominent role in catalyzing phase I xenobiotic biotransformation and account for about 75% of the total metabolism of commercially available drugs, including chemotherapeutics. The gene...
7.
Nafie M, Ali M, Youssef M
J Biochem Mol Toxicol . 2024 Mar; 38(4):e23690. PMID: 38493304
The cytotoxic activity, EGFR/VEGFR2 target inhibition, apoptotic activity, RT-PCR gene expression, in vivo employing a solid-Ehrlich carcinoma model, and in silico investigations for highlighting the binding affinity of eight quinoxaline...
8.
Hassan E, Elsaid A, Abou-Elzahab M, El-Refaey A, Elmougy R, Youssef M
Biochem Genet . 2023 Aug; 62(2):1304-1324. PMID: 37594641
The kidney lost a lot of protein in the urine when you have nephrotic syndrome (NS). Clinical manifestations mostly common in NS include massive proteinuria, hypoalbuminemia, hyperlipidemia, and edema. Idiopathic...
9.
Al-Adl M, El-Said A, El-Sebaie A, Refaat S, Youssef M
Gene . 2023 Jul; 883:147673. PMID: 37506988
Background: The frequency of hematological malignancies is increasing universally, and over the last few decades, a significant increase in the incidence of B-chronic lymphocytic leukemia (B-CLL) has been observed. Many...
10.
El-Saudi A, Altouhamy M, Shaaban S, Badria F, Youssef M, El-Senduny F
Curr Res Pharmacol Drug Discov . 2022 Dec; 3:100134. PMID: 36568265
Ovarian cancer (OC) is the 7th most common cancer in women world-wide and the 3rd most common female cancer. For the treatment of OC, there is no successful therapeutic. The...